Govt Job: For Ph.D at ACTREC – Salary Rs. 60,000 pm

The Section of molecular epidemiology and population genetics at the Center for Cancer Epidemiology, ACTREC, Tata Memorial Center, Mumbai, conducts large scale cutting edge research to understand the etiology and prognostic factors for cancer.

The Centre collaborates with International leaders to conduct genotyping (GWAS) and sequencing (Whole genome and whole exome sequencing) so as to understand role of genetics in cancer causation and progression.

Applications are invited for the post of ‘Post Doctorate Fellow’ to work on projects related to NGS in collaboration with IIT Mumbai.

The project will involve NGS data analysis to set up a pipeline that can be used for identification of biomarkers.

Post : Post Doctorate Fellow – 01 Post

Consolidated Salary : Rs. 60,000/- per months.

Place of work : CCE, Kharghar

Norms : PhD in Computational Biology / Bioinformatics. Candidates with Background in programming will be preferred.

Candidates with background in Computer Science / Engineering willing to work in area of genomics also eligible.

Duration : Six months and may be extendable

Interested candidate may send scan copy of their updated resume with the relevant documents to the email id tmc.ccerecruitment@gmail.com. Please mention the ‘Job Application for the post of “Post Doctorate Fellow” in the subject line.

Last date for document submission on or before 04th February, 2022.

Eligible candidate will be informed about interview details through email.

Related Posts

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

UP expands food, drug testing capacity across all 18 divisions

UP expands food, drug testing capacity across all 18 divisions

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi